Department of Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan.
Ann Surg Oncol. 2021 Oct;28(11):6769-6779. doi: 10.1245/s10434-021-09751-z. Epub 2021 Mar 1.
In terms of anatomical liver sectionectomy approaches, both a central hepatectomy (CH) and major hepatectomy (MH) are feasible options for a centrally located hepatocellular carcinoma (HCC).
We retrospectively reviewed the surgical outcomes of central HCC patients who underwent CH or MH. MH includes hemihepatectomy or trisectionectomy, whereas CH involves a left medial sectionectomy, right anterior sectionectomy, or central bisectionectomy. The surgical outcomes were compared before and after propensity score matching (PSM).
A total of 233 patients were enrolled, including 132 in the CH group and 101 in the MH group. The MH group cases were pathologically more advanced and had poorer overall survival rates than the CH group. After PSM, 68 patients were selected into each group, both of which showed similar overall and recurrence-free survival outcomes. The CH group showed a tendency for a longer operation time; however, other perioperative outcomes were similar between the two groups. Multivariate analyses of our matched HCC patients revealed that the type of surgery (CH or MH) was not an independent prognostic factor. More patients in the matched CH group experienced a repeat hepatectomy for recurrence and no patients in this group underwent a preoperative portal vein embolization.
The short- and long-term surgical outcomes of CH and MH for a centrally located HCC are similar under a matched clinicopathological background. CH has the advantage of not requiring a preoperative portal vein embolization and increased chances of conducting a repeat hepatectomy for recurrence.
在解剖性肝段切除术方面,对于位于中央的肝细胞癌(HCC),中央肝切除术(CH)和大肝切除术(MH)都是可行的选择。
我们回顾性分析了接受 CH 或 MH 的中央 HCC 患者的手术结果。MH 包括半肝切除术或三叶切除术,而 CH 则包括左内叶切除术、右前叶切除术或中部分切除术。在进行倾向评分匹配(PSM)前后比较了手术结果。
共纳入 233 例患者,其中 CH 组 132 例,MH 组 101 例。MH 组病例在病理上更为晚期,总体生存率低于 CH 组。PSM 后,每组各选择 68 例患者,两组总体和无复发生存率相似。CH 组的手术时间较长;但两组的其他围手术期结果相似。对匹配 HCC 患者的多因素分析显示,手术类型(CH 或 MH)不是独立的预后因素。在匹配的 CH 组中,更多患者因复发而接受再次肝切除术,而该组中无患者接受术前门静脉栓塞术。
在匹配的临床病理背景下,CH 和 MH 治疗中央 HCC 的短期和长期手术结果相似。CH 的优势在于不需要术前门静脉栓塞术,并且增加了因复发而再次进行肝切除术的机会。